




Searching News Database: Corautus Genetics
HSMN NewsFeed - 9 Aug 2007
Tikvah Therapeutics Names Jack W. Callicutt Vice President and Chief Financial Officer
Tikvah Therapeutics Names Jack W. Callicutt Vice President and Chief Financial Officer
HSMN NewsFeed - 5 Jun 2007
VIA Pharmaceuticals and Corautus Genetics Complete Merger to Form VIA Pharmaceuticals, Inc.
VIA Pharmaceuticals and Corautus Genetics Complete Merger to Form VIA Pharmaceuticals, Inc.
HSMN NewsFeed - 4 Jun 2007
Corautus Genetics Stockholders Approve Merger with VIA Pharmaceuticals and Related Proposals
Corautus Genetics Stockholders Approve Merger with VIA Pharmaceuticals and Related Proposals
HSMN NewsFeed - 3 Nov 2006
Corautus Genetics Announces Redirection of Focus and Transition Of Officers
Corautus Genetics Announces Redirection of Focus and Transition Of Officers
HSMN NewsFeed - 10 Oct 2006
Corautus Genetics Announces Final Efficacy Results of GENASIS Phase IIb Clinical Trial
Corautus Genetics Announces Final Efficacy Results of GENASIS Phase IIb Clinical Trial
HSMN NewsFeed - 13 Jul 2006
Corautus Genetics Announces Partial Lifting of FDA Clinical Hold and Update on GENASIS Database Lock
Corautus Genetics Announces Partial Lifting of FDA Clinical Hold and Update on GENASIS Database Lock
HSMN NewsFeed - 19 Apr 2006
Corautus Genetics Inc. Names Todd Stallings as Vice President - Clinical Operations
Corautus Genetics Inc. Names Todd Stallings as Vice President - Clinical Operations
HSMN NewsFeed - 10 Apr 2006
Corautus Announces Termination of Patient Enrollment in GENASIS Severe Angina Clinical Trial
Corautus Announces Termination of Patient Enrollment in GENASIS Severe Angina Clinical Trial
Additional items found! 16

Members Archive contains
16 additional stories matching:
Corautus Genetics
(Password required)
Corautus Genetics
(Password required)